HeartBeam Inc
BEAT
Company Profile
Business description
HeartBeam Inc is a medical technology company focused on developing higher resolution ambulatory electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company's proprietary and patented technology platform captures the heart's electrical activity from three dimensions and synthesizes a 12-lead ECG from these signals. The company has received U.S. Food and Drug Administration (FDA) clearance for its ECG solutions.
Contact
2118 Walsh Avenue
Suite 210
Santa ClaraCA95050
USAT: +1 408 899-4443
Sector
Healthcare
Stock type
Defensive
Industry
Health Information Services
Fiscal Year End
31 December 2026
Employees
14
Stocks News & Analysis
stocks
Why don’t good returns guarantee a 5-star rating?
Amy Arnott explains how Morningstar’s stock ratings work.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,932.40 | 64.90 | -0.72% |
| CAC 40 | 8,216.78 | 135.22 | -1.62% |
| DAX 40 | 26,045.37 | 553.27 | -2.08% |
| Dow JONES (US) | 50,759.42 | 848.75 | -1.64% |
| FTSE 100 | 10,689.87 | 191.68 | -1.76% |
| HKSE | 23,275.05 | 233.12 | -0.99% |
| NASDAQ | 24,328.38 | 181.38 | -0.74% |
| Nikkei 225 | 59,024.28 | 163.85 | 0.28% |
| NZX 50 Index | 14,264.29 | 42.67 | -0.30% |
| S&P 500 | 7,340.53 | 76.06 | -1.03% |
| S&P/ASX 200 | 8,821.80 | 61.40 | -0.69% |
| SSE Composite Index | 3,587.83 | 3.25 | 0.09% |